2 Recommendations For Biotech Upside
Hated stocks and biotech are the best bets right now.
Hated stocks and biotech are the best bets right now.
Among the three stocks highlighted in today’s article where analysts at RBC see upside potential over 100% – and which have all earned “Strong Buy”… Read More »Upside Potential Over 100% Have Analysts “Pounding The Table” On These 3 Stocks
Which developmental-stage biotechs have the potential to beat the difficult odds and successfully get their novel drugs to market?
What is this investment opportunity that seems to check all the boxes?
Of the two “best of both worlds” biotech stocks highlighted in today’s article – “companies with both solid drug-development track records and potential COVID-19 vaccine… Read More »These 2 Coronavirus Vaccine Stocks Offer “The Best Of Both Worlds”
Today’s article highlights a group of companies that tend to decline before an election – underperforming the stock market by over one-third as we move… Read More »How To Play This “Post-Election Bounce” Trend
The two biotechs that are the focus of today’s article have been hot this year, with shares of both having experienced triple-digit growth. The reason?… Read More »The Case Against These Two Hot COVID-19 Vaccine Stocks
One billion dollars. Big things happen when a company reaches this threshold in annual sales.
“The fact that more than 9 months of this year have been focused on the space is unfounded. In fact, I don’t remember one industry… Read More »5 Biotech Penny Stocks To Watch Amid An “Unfounded” Time For The Space
While the surge in interest in pharmaceutical stocks this year has been primarily driven by factors related to the COVID-19 pandemic, the author of today’s… Read More »Unmet Needs And Niche Markets: These Pharma Stocks Have The Momentum